Biomarkers and Disease Activity in Patients Treated With Teriflunomide (Aubagio)

NCT03561402 · clinicaltrials.gov ↗

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DRUG: Teriflunomide

Sponsor

McGill University